The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications - PubMed (original) (raw)

Review

The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications

Shi Fang Yan et al. Curr Diab Rep. 2007 Apr.

Abstract

The interaction of glucose-modified and inflammation-promoting ligands with the receptor for advanced glycation end products (RAGE) is emerging as a central mechanism contributing to the diverse complications of diabetes. These ligands, particularly in oligomeric form, bind to RAGE and transduce intracellular signals. The consequences of this interaction, as elucidated in cultured cells and animal models, include upregulation of inflammatory and tissue-degradative pathways. Pharmacologic antagonism of RAGE may hold promise for the treatment of diabetic complications.

PubMed Disclaimer

References

    1. J Clin Invest. 2001 Jul;108(2):261-8 - PubMed
    1. Science. 1999 Jul 9;285(5425):248-51 - PubMed
    1. J Peripher Nerv Syst. 2005 Jun;10(2):144-57 - PubMed
    1. J Clin Invest. 2004 Jun;113(11):1641-50 - PubMed
    1. Exp Eye Res. 2006 May;82(5):807-15 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources